UBS Group’s Humankind US Stock ETF HKND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1
Closed -$32 10502
2025
Q1
$32 Sell
1
-2
-67% -$65 ﹤0.01% 10054
2024
Q4
$95 Sell
3
-31
-91% -$1.02K ﹤0.01% 9659
2024
Q3
$1.13K Buy
34
+30
+750% +$966 ﹤0.01% 8713
2024
Q2
$125 Sell
4
-70
-95% -$2.16K ﹤0.01% 9130
2024
Q1
$2.33K Sell
74
-426
-85% -$12.8K ﹤0.01% 7927
2023
Q4
$14.6K Buy
+500
New +$13.8K ﹤0.01% 7277
2023
Q3
Sell
-376
Closed -$10.6K 9666
2023
Q2
$10.6K Buy
376
+272
+262% +$7.45K ﹤0.01% 7131
2023
Q1
$2.82K Sell
104
-810
-89% -$21.9K ﹤0.01% 8436
2022
Q4
$24.2K Buy
+914
New +$24K ﹤0.01% 7456
2022
Q3
Sell
-18
Closed 10577
2022
Q2
$0 Buy
+18
New +$494 ﹤0.01% 10574
2022
Q1
Sell
-445
Closed -$13K 10510
2021
Q4
$13K Buy
+445
New +$12.8K ﹤0.01% 8450
2021
Q3
Sell
-1,202
Closed -$33K 9763
2021
Q2
$33K Buy
+1,202
New +$32.7K ﹤0.01% 6827

Other funds holding HKND

UBS Group's HKND Position: Q2 2025 in Review

UBS Group sold out of Humankind US Stock ETF (HKND) in Q2 2025, closing a stake of 1 share — an estimated $32 sold.

UBS Group first reported a position in HKND in Q2 2021 and held it in 12 quarters. The position peaked at $33K in Q2 2021. 7 funds tracked by Wall St. Rank hold HKND as of Q2 2025.

  • UBS Group reported no remaining Humankind US Stock ETF position as of Q2 2025 after selling out during the quarter.
  • UBS Group sold 1 Humankind US Stock ETF share in Q2 2025, an estimated $32.
  • UBS Group first reported a position in Humankind US Stock ETF in Q2 2021 and held it in 12 quarters.
  • UBS Group's Humankind US Stock ETF position peaked at $33K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Humankind US Stock ETF as of Q2 2025.

Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.